Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Adams

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Eclinicalmedicine|December 25, 2024
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome setRobert Samuel, Stephen R Knight, Richard Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal CancerMartin Scurr, Tom Pembroke, Anja Bloom, et al.
British Journal of Haematology|June 17, 2026
Outcome of treatment with trametinib in adults with histiocytic neoplasms in the United KingdomRodothea Amerikanou, Talha Munir, Kristian Bowles, et al.
Journal of Clinical Pathology|March 8, 2022
FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testingSusan D Richman, Gemma Hemmings, Helen Roberts, et al.
BMJ Open|June 28, 2017
Talking about human papillomavirus and cancer: development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary dataMaggie Hendry, Diana Pasterfield, Simon Gollins, et al.
The Lancet. Gastroenterology & Hepatology|December 20, 2017
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trialRichard Adams, Ewan Brown, Louise Brown, et al.
BMJ Open|April 27, 2016
Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultationsMaggie Hendry, Di Pasterfield, Richard Adams, et al.
Human Mutation|April 16, 2013
Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancerChristopher G Smith, Marc Naven, Rebecca Harris, et al.
Health Technology Assessment (Winchester, England)|March 21, 2024
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCTVicky Coyle, Caroline Forde, Richard Adams, et al.
Trials|May 29, 2020
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trialCaroline Forde, Ronan McMullan, Mike Clarke, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Eclinicalmedicine|December 25, 2024
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome setRobert Samuel, Stephen R Knight, Richard Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal CancerMartin Scurr, Tom Pembroke, Anja Bloom, et al.
British Journal of Haematology|June 17, 2026
Outcome of treatment with trametinib in adults with histiocytic neoplasms in the United KingdomRodothea Amerikanou, Talha Munir, Kristian Bowles, et al.
Journal of Clinical Pathology|March 8, 2022
FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testingSusan D Richman, Gemma Hemmings, Helen Roberts, et al.
BMJ Open|June 28, 2017
Talking about human papillomavirus and cancer: development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary dataMaggie Hendry, Diana Pasterfield, Simon Gollins, et al.
The Lancet. Gastroenterology & Hepatology|December 20, 2017
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trialRichard Adams, Ewan Brown, Louise Brown, et al.
BMJ Open|April 27, 2016
Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultationsMaggie Hendry, Di Pasterfield, Richard Adams, et al.
Human Mutation|April 16, 2013
Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancerChristopher G Smith, Marc Naven, Rebecca Harris, et al.
Health Technology Assessment (Winchester, England)|March 21, 2024
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCTVicky Coyle, Caroline Forde, Richard Adams, et al.
Trials|May 29, 2020
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trialCaroline Forde, Ronan McMullan, Mike Clarke, et al.
Pageof 15